Gut Microbiome: The Interplay of an "Invisible Organ" with Herbal Medicine and Its Derived Compounds in Chronic Metabolic Disorders

Int J Environ Res Public Health. 2022 Oct 11;19(20):13076. doi: 10.3390/ijerph192013076.

Abstract

Resembling a concealed "organ" in a holobiont, trillions of gut microbes play complex roles in the maintenance of homeostasis, including participating in drug metabolism. The conventional opinion is that most of any drug is metabolized by the host and that individual differences are principally due to host genetic factors. However, current evidence indicates that only about 60% of the individual differences in drug metabolism are attributable to host genetics. Although most common chemical drugs regulate the gut microbiota, the gut microbiota is also known to be involved in drug metabolism, like the host. Interestingly, many traditional herbal medicines and derived compounds are biotransformed by gut microbiota, manipulating the compounds' effects. Accordingly, the gut microbiota and its specified metabolic pathways can be deemed a promising target for promoting drug efficacy and safety. However, the evidence regarding causality and the corresponding mechanisms concerning gut microbiota and drug metabolism remains insufficient, especially regarding drugs used to treat metabolic disorders. Therefore, the present review aims to comprehensively summarize the bidirectional roles of gut microbiota in the effects of herbal medicine in metabolic diseases to provide vital clues for guiding the clinical application of precision medicine and personalized drug development.

Keywords: drug metabolism; drug–gut microbe interaction; gut microbiota; herbal medicine; metabolic disorder.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chronic Disease
  • Gastrointestinal Microbiome*
  • Herbal Medicine
  • Humans
  • Metabolic Diseases* / drug therapy
  • Phytotherapy
  • Plants, Medicinal*